Synovagen Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
About Synovagen Life Sciences
Synovagen Life Sciences Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2016 (Eight years and two months 21 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Parthasarathy Ranganathan, Prudhvi Yalla, Dasari Prasad, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TG2016PTC113273
- Company No.
113273
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2016
- Date of AGM
04 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Synovagen Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parthasarathy Ranganathan  | Whole-Time Director | 30-Jan-2017 | Current |
| Prudhvi Yalla | Director | 12-Apr-2018 | Current |
| Dasari Prasad | Director | 04-Dec-2020 | Current |
| Varaprasad Dasari | Whole-Time Director | 06-Dec-2016 | Current |
Financial Performance of Synovagen Life Sciences.
Synovagen Life Sciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Synovagen Life Sciences?
In 2017, Synovagen Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Excorp Biomedical India Private LimitedPrudhvi Yalla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synovagen Life Sciences?
Unlock and access historical data on people associated with Synovagen Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synovagen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synovagen Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
